# Carvedilol SR Study for Biomarkers From Blood and Urine and Safety of in Patients With Heart Failure With Preserved Ejection Fraction

> **NCT03948685** · PHASE4 · UNKNOWN · sponsor: **Yonsei University** · enrollment: 300 (estimated)

## Conditions studied

- Heart Failure With Preserved Ejection Fraction

## Interventions

- **DRUG:** Carvedilol SR
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03948685
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05
- **Primary completion:** 2020-12
- **Final completion:** 2021-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2019-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03948685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03948685, "Carvedilol SR Study for Biomarkers From Blood and Urine and Safety of in Patients With Heart Failure With Preserved Ejection Fraction". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03948685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*